Global Botulinum Toxin A Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Botulinum Toxin A Market
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.

The global Botulinum Toxin A market size is projected to reach US$ 15790 million by 2028, from US$ 6563.4 million in 2021, at a CAGR of 13.2% during 2022-2028.

Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.

United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.

In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Botulinum Toxin A market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Botulinum Toxin A market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Botulinum Toxin A market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Botulinum Toxin A market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Botulinum Toxin A market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Botulinum Toxin A Breakdown Data by Type

50iu

100iu

Other

Botulinum Toxin A Breakdown Data by Application

Medical Use

Beauty Use

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Allergan (AGN)

Ipsen

Merz Pharmaceuticals

Medytox

BTXA

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Botulinum Toxin A Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 50iu

1.2.3 100iu

1.2.4 Other

1.3 Market by Application

1.3.1 Global Botulinum Toxin A Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Medical Use

1.3.3 Beauty Use

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Botulinum Toxin A Market Perspective (2017-2028)

2.2 Botulinum Toxin A Growth Trends by Region

2.2.1 Botulinum Toxin A Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Botulinum Toxin A Historic Market Size by Region (2017-2022)

2.2.3 Botulinum Toxin A Forecasted Market Size by Region (2023-2028)

2.3 Botulinum Toxin A Market Dynamics

2.3.1 Botulinum Toxin A Industry Trends

2.3.2 Botulinum Toxin A Market Drivers

2.3.3 Botulinum Toxin A Market Challenges

2.3.4 Botulinum Toxin A Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Botulinum Toxin A Players by Revenue

3.1.1 Global Top Botulinum Toxin A Players by Revenue (2017-2022)

3.1.2 Global Botulinum Toxin A Revenue Market Share by Players (2017-2022)

3.2 Global Botulinum Toxin A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Botulinum Toxin A Revenue

3.4 Global Botulinum Toxin A Market Concentration Ratio

3.4.1 Global Botulinum Toxin A Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Botulinum Toxin A Revenue in 2021

3.5 Botulinum Toxin A Key Players Head office and Area Served

3.6 Key Players Botulinum Toxin A Product Solution and Service

3.7 Date of Enter into Botulinum Toxin A Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Botulinum Toxin A Breakdown Data by Type

4.1 Global Botulinum Toxin A Historic Market Size by Type (2017-2022)

4.2 Global Botulinum Toxin A Forecasted Market Size by Type (2023-2028)

5 Botulinum Toxin A Breakdown Data by Application

5.1 Global Botulinum Toxin A Historic Market Size by Application (2017-2022)

5.2 Global Botulinum Toxin A Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Botulinum Toxin A Market Size (2017-2028)

6.2 North America Botulinum Toxin A Market Size by Type

6.2.1 North America Botulinum Toxin A Market Size by Type (2017-2022)

6.2.2 North America Botulinum Toxin A Market Size by Type (2023-2028)

6.2.3 North America Botulinum Toxin A Market Share by Type (2017-2028)

6.3 North America Botulinum Toxin A Market Size by Application

6.3.1 North America Botulinum Toxin A Market Size by Application (2017-2022)

6.3.2 North America Botulinum Toxin A Market Size by Application (2023-2028)

6.3.3 North America Botulinum Toxin A Market Share by Application (2017-2028)

6.4 North America Botulinum Toxin A Market Size by Country

6.4.1 North America Botulinum Toxin A Market Size by Country (2017-2022)

6.4.2 North America Botulinum Toxin A Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Botulinum Toxin A Market Size (2017-2028)

7.2 Europe Botulinum Toxin A Market Size by Type

7.2.1 Europe Botulinum Toxin A Market Size by Type (2017-2022)

7.2.2 Europe Botulinum Toxin A Market Size by Type (2023-2028)

7.2.3 Europe Botulinum Toxin A Market Share by Type (2017-2028)

7.3 Europe Botulinum Toxin A Market Size by Application

7.3.1 Europe Botulinum Toxin A Market Size by Application (2017-2022)

7.3.2 Europe Botulinum Toxin A Market Size by Application (2023-2028)

7.3.3 Europe Botulinum Toxin A Market Share by Application (2017-2028)

7.4 Europe Botulinum Toxin A Market Size by Country

7.4.1 Europe Botulinum Toxin A Market Size by Country (2017-2022)

7.4.2 Europe Botulinum Toxin A Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Botulinum Toxin A Market Size (2017-2028)

8.2 Asia-Pacific Botulinum Toxin A Market Size by Type

8.2.1 Asia-Pacific Botulinum Toxin A Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Botulinum Toxin A Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Botulinum Toxin A Market Share by Type (2017-2028)

8.3 Asia-Pacific Botulinum Toxin A Market Size by Application

8.3.1 Asia-Pacific Botulinum Toxin A Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Botulinum Toxin A Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Botulinum Toxin A Market Share by Application (2017-2028)

8.4 Asia-Pacific Botulinum Toxin A Market Size by Region

8.4.1 Asia-Pacific Botulinum Toxin A Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Botulinum Toxin A Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Botulinum Toxin A Market Size (2017-2028)

9.2 Latin America Botulinum Toxin A Market Size by Type

9.2.1 Latin America Botulinum Toxin A Market Size by Type (2017-2022)

9.2.2 Latin America Botulinum Toxin A Market Size by Type (2023-2028)

9.2.3 Latin America Botulinum Toxin A Market Share by Type (2017-2028)

9.3 Latin America Botulinum Toxin A Market Size by Application

9.3.1 Latin America Botulinum Toxin A Market Size by Application (2017-2022)

9.3.2 Latin America Botulinum Toxin A Market Size by Application (2023-2028)

9.3.3 Latin America Botulinum Toxin A Market Share by Application (2017-2028)

9.4 Latin America Botulinum Toxin A Market Size by Country

9.4.1 Latin America Botulinum Toxin A Market Size by Country (2017-2022)

9.4.2 Latin America Botulinum Toxin A Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Botulinum Toxin A Market Size (2017-2028)

10.2 Middle East & Africa Botulinum Toxin A Market Size by Type

10.2.1 Middle East & Africa Botulinum Toxin A Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Botulinum Toxin A Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Botulinum Toxin A Market Share by Type (2017-2028)

10.3 Middle East & Africa Botulinum Toxin A Market Size by Application

10.3.1 Middle East & Africa Botulinum Toxin A Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Botulinum Toxin A Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Botulinum Toxin A Market Share by Application (2017-2028)

10.4 Middle East & Africa Botulinum Toxin A Market Size by Country

10.4.1 Middle East & Africa Botulinum Toxin A Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Botulinum Toxin A Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Allergan (AGN)

11.1.1 Allergan (AGN) Company Details

11.1.2 Allergan (AGN) Business Overview

11.1.3 Allergan (AGN) Botulinum Toxin A Introduction

11.1.4 Allergan (AGN) Revenue in Botulinum Toxin A Business (2017-2022)

11.1.5 Allergan (AGN) Recent Developments

11.2 Ipsen

11.2.1 Ipsen Company Details

11.2.2 Ipsen Business Overview

11.2.3 Ipsen Botulinum Toxin A Introduction

11.2.4 Ipsen Revenue in Botulinum Toxin A Business (2017-2022)

11.2.5 Ipsen Recent Developments

11.3 Merz Pharmaceuticals

11.3.1 Merz Pharmaceuticals Company Details

11.3.2 Merz Pharmaceuticals Business Overview

11.3.3 Merz Pharmaceuticals Botulinum Toxin A Introduction

11.3.4 Merz Pharmaceuticals Revenue in Botulinum Toxin A Business (2017-2022)

11.3.5 Merz Pharmaceuticals Recent Developments

11.4 Medytox

11.4.1 Medytox Company Details

11.4.2 Medytox Business Overview

11.4.3 Medytox Botulinum Toxin A Introduction

11.4.4 Medytox Revenue in Botulinum Toxin A Business (2017-2022)

11.4.5 Medytox Recent Developments

11.5 BTXA

11.5.1 BTXA Company Details

11.5.2 BTXA Business Overview

11.5.3 BTXA Botulinum Toxin A Introduction

11.5.4 BTXA Revenue in Botulinum Toxin A Business (2017-2022)

11.5.5 BTXA Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer